GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luye Pharma Group Ltd (STU:LUP) » Definitions » Shiller PE Ratio

Luye Pharma Group (STU:LUP) Shiller PE Ratio : 10.80 (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Luye Pharma Group Shiller PE Ratio?

As of today (2024-09-22), Luye Pharma Group's current share price is €0.324. Luye Pharma Group's E10 for the fiscal year that ended in Dec23 was €0.03. Luye Pharma Group's Shiller PE Ratio for today is 10.80.

The historical rank and industry rank for Luye Pharma Group's Shiller PE Ratio or its related term are showing as below:

STU:LUP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.95   Med: 13.44   Max: 35
Current: 10.43

During the past 13 years, Luye Pharma Group's highest Shiller PE Ratio was 35.00. The lowest was 4.95. And the median was 13.44.

STU:LUP's Shiller PE Ratio is ranked better than
88.03% of 468 companies
in the Drug Manufacturers industry
Industry Median: 23.995 vs STU:LUP: 10.43

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Luye Pharma Group's adjusted earnings per share data of for the fiscal year that ended in Dec23 was €0.018. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.03 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Luye Pharma Group Shiller PE Ratio Historical Data

The historical data trend for Luye Pharma Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luye Pharma Group Shiller PE Ratio Chart

Luye Pharma Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.29 8.36 9.13 9.90 12.88

Luye Pharma Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.13 - 9.90 - 12.88

Competitive Comparison of Luye Pharma Group's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Luye Pharma Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luye Pharma Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luye Pharma Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Luye Pharma Group's Shiller PE Ratio falls into.



Luye Pharma Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Luye Pharma Group's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.324/0.03
=10.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Luye Pharma Group's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Luye Pharma Group's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.018/114.7809*114.7809
=0.018

Current CPI (Dec23) = 114.7809.

Luye Pharma Group Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.026 99.000 0.030
201512 0.032 100.600 0.037
201612 0.037 102.600 0.041
201712 0.039 104.500 0.043
201812 0.052 106.500 0.056
201912 0.056 111.200 0.058
202012 0.028 111.500 0.029
202112 -0.005 113.108 -0.005
202212 0.024 115.116 0.024
202312 0.018 114.781 0.018

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Luye Pharma Group  (STU:LUP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Luye Pharma Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Luye Pharma Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Luye Pharma Group Business Description

Traded in Other Exchanges
Address
No. 15 Chuang Ye Road, High-tech Industrial Development Zone, Shandong, Yantai, CHN, 264003
Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on developing, producing, and selling pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for global use in Asia, Europe, and the United States.

Luye Pharma Group Headlines

No Headlines